Dan Bongino, a conservative radio talk show host, threatened to quit his show due to a Covid-19 vaccine mandate.
Westwood One, the company that airs Bongino’s show, is owned by radio station conglomerate Cumulus Media. Cumulus announced a Covid-19 vaccine mandate for employees in August, and some have already been let go for not complying by the September 27 deadline (Washington Post). Bongino, who has been vaccinated, is fighting against it.
During his show on Monday, Bongino said he would not be “letting go”, in regards to the vaccine mandate made by Cumulus. Although he has been vaccinated, he expressed his dismay at personalities who “have a lower profile than” him have already been fired for choosing to not get vaccinated.
“I believe these vaccine mandates are unethical. I believe they’re immoral. I believe they don’t take into account the science of natural immunity due to a prior infection. I believe they’re broad-based and don’t take into account individual circumstances of why they may or may not want to take a vaccine. And they’re antithetical to everything I believe in. So, I’ll say again, I’m not going to let this go.”
Fox Nation, a streaming service of Fox News, simulcasts Bongino’s show and airs his Saturday night show. The media giant has required its employees to disclose their vaccination status, or get tested daily. Bongino has seemingly remained silent on their vaccine policy. In fact, other Fox News personalities who have been vocal in their criticism of the vaccine and mandates have kept mum about the policy within their company. According to a memo sent by Human Resources at Fox Corp last week, over 90% of “rank and file” employees are fully vaccinated.
Bongino is a former Secret Service agent and New York City cop. He gained notoriety as a conservative figure in the media while former President Donald Trump was in office. After the death of conservative talk show host Rush Limbaugh, Bongino was given Limbaugh’s former time slot, weekdays from 12 to 3 PM, in May of this year. He was diagnosed with Hodgkin’s Lymphoma last year and finished treatment for it in March.